HERMIONE: A phase 2, randomized, open label trial comparing...

Annals of Oncology 2016 / 10 Vol. 27; Iss. suppl_6

HERMIONE: A phase 2, randomized, open label trial comparing MM-302 plus trastuzumab with chemotherapy of physician's choice plus trastuzumab, in anthracycline naive HER2-positive, locally advanced/metastatic breast cancer patients previously treated with pertuzumab and T-DM1

Castan, J. Cortes, Verma, S., Hurvitz, S., Krop, I.E., Tripathy, D., Yardley, D.A., Dionne, M., Reynolds, J., Wickham, T., Molnar, I., Miller, K.
How much do you like this book?
What’s the quality of the file?
Download the book for quality assessment
What’s the quality of the downloaded files?
Volume:
27
Language:
english
Journal:
Annals of Oncology
DOI:
10.1093/annonc/mdw365.94
Date:
October, 2016
File:
PDF, 42 KB
english, 2016
Conversion to is in progress
Conversion to is failed